U.S. IPOs Hit $251B First-Half Record, Pacing for 2021 Beat

The U.S. equity issuance market just put up the biggest first half in
history. Through June 26, 2026, U.S. issuers raised
$251 billion in IPOs — surpassing the prior midyear
record set during the 2021 listing boom, according to
Renaissance Capital data reported by Reuters.
Two landmark deals drove the print: SpaceX’s
$86.2 billion IPO and Alphabet’s
$85 billion equity raise to fund its AI buildout. Together,
those two transactions are larger than all U.S. IPO proceeds from 2023, 2024,
and 2025 combined.

The headline number tells one story. The composition tells another: 11
separate IPOs cleared the $1 billion threshold, the 2026 debutants are up a
weighted-average 16% from their offer prices, and the
average IPO valuation is roughly three times last year’s
average and 10 times the 2022 average. This is not a
“SpaceX plus everyone else” tape.

The H1 2026 record in context

Renaissance Capital’s
Q2 2026 review
notes that 48 IPOs priced in the quarter alone, raising
$104.9 billion — the largest single-quarter total since
2021, even before SpaceX. That follows a Q1 that saw a sharp volatility
spike absorbed and then faded. The table below stacks H1 2026 against the
two prior peak years.

Period IPO proceeds ($B) Deals > $1B Notes
H1 2026 251.0 11 Record; SpaceX + Alphabet drive ~68%
H1 2021 (prior record) ~171.0 multiple SPAC boom; mostly mid-cap deals
H1 2025 ~13.0 few Slow market, recovery year
Q2 2026 alone 104.9 10 Largest quarter since 2021
Sources: Reuters/Yahoo Finance, June 27, 2026; Renaissance Capital 2Q 2026 US IPO Market Review; Renaissance Capital IPO Proceeds historical data. H1 2021 and H1 2025 are approximate annual-pace figures.

The deals that defined the half

Two transactions account for roughly $171 billion — about 68% of the
half-year total. The other nine $1B-plus deals fill out a respectable middle
of the calendar.

Issuer Ticker Proceeds ($B) Listing date Theme
SpaceX SPCX 86.2 Jun 12, 2026 Aerospace / satellite broadband
Alphabet (secondary) GOOGL 85.0 H1 2026 AI infrastructure raise
Cerebras Systems CBRS ~3.5 May 14, 2026 AI accelerator silicon
Other 8 > $1B deals ~30 (combined) Q1–Q2 Industrials, healthcare, fintech
Top deals subtotal ~205 82% of H1 total
Sources: Nasdaq IPO summary for SpaceX (SPCX); SpaceX IPO reference (Wikipedia); Reuters/Yahoo Finance summary, June 27, 2026. Cerebras proceeds approximate; Alphabet figure is a follow-on equity raise included in Renaissance’s broader IPO proceeds tally.

Visualizing the gap: 2026 vs the last record

The 2021 SPAC-and-tech boom was the previous high-water mark. 2026 is
already roughly 47% larger at the same point in the
calendar — with two quarters still to go.

U.S. IPO proceeds, first half of each year Bar chart comparing first-half U.S. IPO proceeds in 2021 through 2026; H1 2026 sets a new record at $251 billion. U.S. IPO proceeds — first half of each year ($B) H1 2026 sets a new record at $251B 0 50 100 150 200 250 H1 2021 $171 H1 2022 $24 H1 2023 $13 H1 2024 $20 H1 2025 $13 H1 2026 $251
Sources: Renaissance Capital IPO Proceeds; Reuters/Yahoo Finance, June 27, 2026. Prior-year H1 figures are approximate.

SpaceX is the asterisk — but not the only story

SpaceX’s
June 12 listing on the Nasdaq under ticker SPCX
priced at $135, opened at $150, and reached a session high near $176 before
trading down. The IPO eclipsed Saudi Aramco’s 2019 $25.6 billion deal —
which had held the record for seven years — by more than three times.
According to
CNBC’s closing recap,
SPCX finished its first session at $161, a 19% gain.

The follow-through has been bumpier. Across a four-session stretch in
late June, SpaceX shed roughly $400 billion in market capitalization,
including a single-day decline of about 16%. The stock remains above its
IPO price, but the post-debut volatility is a useful reminder that even
record demand at issuance does not lock in clean aftermarket performance.

Strip SpaceX out and you still have a record-paced market. Goldman Sachs,
quoted in
the Reuters/Yahoo Finance report,
said volumes “are advancing rapidly” across products, not just
mega-cap tech. Cerebras Systems, the wafer-scale AI chipmaker, debuted on
May 14 and opened roughly 89% above its IPO price, illustrating the same
demand for AI infrastructure exposure that powered SpaceX’s book.

Why now? Three forces lined up

  • AI capex demand. Hyperscalers, model labs, and
    silicon vendors are funding multi-hundred-billion-dollar capacity buildouts.
    SpaceX’s Starlink expansion, Alphabet’s data-center buildout, and
    Cerebras’ scaling all push founders and CFOs to tap the largest available
    pool of capital: public equity.
  • A receptive S&P 500. Index gains, narrow credit
    spreads, and steady-but-not-tight monetary policy create the “risk-on,
    multiple-friendly” backdrop bankers wait for. With dispersion compressed
    and indices near highs, real-money allocators have to take on new issuance
    to keep up with their benchmarks.
  • A four-year pipeline backlog. Companies that
    postponed listings during 2022–2024 are flooding back. JPMorgan
    flagged in a June note
    that buyout-backed companies are now the dominant supply source, as private
    equity firms turn portfolio investments into liquidity events.

Risks underneath the headline

Three caveats temper the celebration:

  • Concentration. Two deals drove ~68% of proceeds.
    That number flatters the breadth of the market and would compress sharply
    if one of these issuers were excluded.
  • Valuation stretch. Average IPO valuations are
    ~10× their 2022 level. A single sentiment reset — an AI capex
    disappointment, a credit event, or a renewed inflation surprise — can
    re-rate the cohort fast.
  • Calendar risk. Morgan Stanley
    flagged
    that Q3 deals are likely to be front-loaded ahead of midterm-election
    volatility, meaning supply may compress into July and August. The H2 print
    will tell whether 2026 sets a full-year record or sees H2 cool sharply.

What to watch into year-end

  • Renaissance IPO ETF (NYSE: IPO). The cleanest market
    proxy for newly listed share performance. It captures the cohort effect:
    when broken IPOs spike, sentiment turns and the new-issue window closes.
  • Bookbuild oversubscription levels. Renaissance reports
    these in its quarterly review. Dropping coverage ratios are an early sign
    that demand is being absorbed faster than issuers can supply paper.
  • Buyout-backed pipeline. JPMorgan identifies PE-backed
    exits as the dominant H2 supply source. The pace of S-1 filings from PE
    sponsors will pre-signal whether the calendar can sustain Q2’s pace.

Sources

Disclosure: This article was produced with AI assistance and reviewed before publication. It is for informational purposes only and is not investment advice.

Leave a Comment